STAT3 and myelodysplastic syndrome: This could be a likely scenario in the IL-6-rich BM microenvironment of MDS patients, since MDSCs are known to escape necroptosis after DNA methylation following IL-6-induced STAT3 signaling in the context of cancer [88].